← All trials
NCT05058976
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 15, 2021
- Primary completion
- Sep 30, 2027
- Completion date
- Sep 30, 2027
- First posted
- Sep 28, 2021
- Last posted
- Oct 6, 2021
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of PittsburghLead sponsor
- National Institutes of Health (NIH)Collaborator
- University of PittsburghSponsor investigator
- University of PittsburghOverall official - principal investigator
- National Institute on Aging (NIA)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.